title: Disentangling the ultrafiltration rate-mortality association: the respective roles of session length and weight gain.
abstract: OBJECTIVE
  Rapid ultrafiltration rate is associated with increased mortality among hemodialysis patients. Ultrafiltration rates are determined by interdialytic weight gain and session length. Although both interdialytic weight gain and session length have been linked to mortality, the relationship of each to mortality, independent of the other, is not adequately defined. This study was designed to evaluate whether shorter session length independent of weight gain and larger weight gain independent of session length are associated with increased mortality.
  
  
  METHODS
  Data were taken from a national cohort of 14,643 prevalent, thrice-weekly, in-center hemodialysis patients dialyzing from 2005 to 2009 (median survival time, 25 months) at a single dialysis organization. Patients with adequate urea clearance and delivered dialysis session ≥240 and <240 minutes were pair-matched on interdialytic weight gain (n=1794), and patients with weight gain ≤3 and >3 kg were pair-matched on session length (n=2114); mortality associations were estimated separately.
  
  
  RESULTS
  Compared with delivered session length ≥240, session length <240 minutes was associated with increased all-cause mortality (adjusted hazard ratio [95% confidence interval], 1.32 [1.03 to 1.69]). Compared with weight gain ≤3, weight gain >3 kg was associated with increased mortality (1.29 [1.01 to 1.65]). The associations were consistent across strata of age, sex, weight, and weight gain and session length. Secondary analyses demonstrated dose-response relationships between both and mortality.
  
  
  CONCLUSIONS
  Among patients with adequate urea clearance, shorter dialysis session length and greater interdialytic weight gain are associated with increased mortality; thus, both are viable targets for directed intervention.
authors.affiliation: Renal Division, Department of Medicine, Brigham and Women's Hospital, Boston, Massachusetts 02115, USA. jflythe@partners.org
authors.forename: Jennifer E
authors.initials: JE
authors.lastname: Flythe
authors.forename: Gary C
authors.initials: GC
authors.lastname: Curhan
authors.forename: Steven M
authors.initials: SM
authors.lastname: Brunelli
mesh_terms: D000368:Aged; D015415:Biomarkers / Q000097:blood; D016009:Chi-Square Distribution; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D015999:Multivariate Analysis; D016016:Proportional Hazards Models; D006435:Renal Dialysis / Q000009:adverse effects / Q000401:mortality*; D051436:Renal Insufficiency, Chronic / Q000097:blood / Q000401:mortality* / Q000628:therapy*; D018570:Risk Assessment; D012307:Risk Factors; D013997:Time Factors; D016896:Treatment Outcome; D014481:United States; D014508:Urea / Q000097:blood; D015430:Weight Gain
chemical_list: D015415:Biomarkers; D014508:Urea